A Study to Test Radium-223 With Docetaxel in Patients With Prostate Cancer (NCT03574571)
Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone. Earlier studies helped show that the combination is safe, but the combination has not been proven to work better than either drug alone. The goal of this study is to find out if combining docetaxel and radium-223 is better than giving either drug by itself.
Who can join: Review the eligibility criteria below.
Location: Banner MD Anderson Cancer Center — Gilbert, Arizona
Age range: 18 Years
🧪 Interventions in This Study
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistFull eligibility criteria are available on the official NIH protocol. View the criteria ↗
📍 All Participating Trial Locations (72 Sites)
Showing the first 25 of 72 sites.
- Banner MD Anderson Cancer Center — Gilbert, Arizona
- Yale University- Yale Cancer Center — New Haven, Connecticut
- Helen Graham Cancer Center (Christiana Care) — Newark, Delaware
- Boca Raton Regional Hospital — Boca Raton, Florida
- Mount Sinai Medical Center (Miami) — Miami, Florida
- Rush University Medical Center — Chicago, Illinois
- Indiana University — Indianapolis, Indiana
- Ochsner Cancer Institute — New Orleans, Louisiana
- University of Maryland Medical Center — Baltimore, Maryland
- University of Massachusetts — Worcester, Massachusetts
- University of Michigan Cancer Center — Ann Arbor, Michigan
- University of Minnesota — Minneapolis, Minnesota
- Nebraska Cancer Specialists — Omaha, Nebraska
- XCancer Omaha / Urology Cancer Center — Omaha, Nebraska
- Comprehensive Cancer Centers of Nevada — Las Vegas, Nevada
- Memorial Sloan Kettering Basking Ridge — Basking Ridge, New Jersey
- MD Anderson Cancer Center at Cooper — Camden, New Jersey
- Memorial Sloan Kettering Monmouth — Middletown, New Jersey
- Memorial Sloan Kettering Bergen — Montvale, New Jersey
- New Jersey Urology — Saddle Brook, New Jersey
- New Mexico Oncology and Hematology — Albuquerque, New Mexico
- University of Buffalo — Buffalo, New York
- Roswell Park Cancer Institute — Buffalo, New York
- Memorial Sloan Kettering Commack — Commack, New York
- Memorial Sloan Kettering Westchester — Harrison, New York
📞 Contact the Study Coordinator
Phone: (877) 632-6789
Coordinator details come directly from the registered NIH protocol. Confirm the study is still recruiting before traveling.
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.
More studies in Prostate Cancer
- A Study of Apalutamide (JNJ-56021927, ARN-509) Plus Androgen Deprivation Therapy (ADT) Versus ADT in Participants With mHSPC — Homewood, Alabama
- A Study in Which Non-metastatic Castration-resistant Prostate Cancer (nmCRPC) Patients for Whom a Decision to Treat With Darolutamide Has Been Made Before Enrollment Are Observed and Certain Outcomes Are Described — Homewood, Alabama
- Stereotactic Ablative Radiation Therapy for Prostate Cancer — Charleston, South Carolina
- A Study of Stereotactic Body Radiation Therapy (SBRT) Without Androgen Deprivation Therapy (ADT) in People With Unfavorable Intermediate-Risk Prostate Cancer — Basking Ridge, New Jersey
- A Study of Abiraterone Acetate Plus Prednisone With or Without Abemaciclib (LY2835219) in Participants With Prostate Cancer — Phoenix, Arizona
- Neoadjuvant Enoblituzumab (MGA271) in Men With Localized Intermediate and High-Risk Prostate Cancer — Baltimore, Maryland
Explore by condition: All Prostate Cancer clinical trials
💡 How to Participate
- Check the checklist above to see if you may qualify.
- Contact the study coordinator using the phone/email above.
- Ask about the visit schedule, what is covered at no cost, and any travel support.
- Confirm with your own doctor before making a decision.